You are here

For Journalists

Gladstone welcomes inquiries from journalists. Our media-relations staff is on hand to provide local, regional, national, and international journalists with accurate information about Gladstone’s research and our investigators’ areas of expertise. We are available to arrange interviews with Gladstone scientists and assist in developing story ideas.

Please contact:

Megan McDevitt, Vice President of Communications
Direct line: 415.734.2019
Mobile: 415.806.6245

 

 


 

Press Releases

January 6, 2016

SAN FRANCISCO, CA—Scientists at the Gladstone Institutes and the University of California, San Francisco (UCSF) have successfully converted human skin cells into fully-functional pancreatic cells.

November 30, 2015

SAN FRANCISCO, CA—In a bid to end the worst epidemic in modern times, the Foundation for AIDS Research (amfAR) is funding an ambitious effort based in San Francisco to eliminate the human immunodeficiency virus (HIV) from those who are infected.

November 30, 2015

SAN FRANCISCO, CA—Researchers from the Gladstone Institutes have shown for the first time that the protein BRCA1 is required for normal learning and memory and is depleted by Alzheimer’s disease.

November 23, 2015

SAN FRANCISCO, CA—Scientists have revealed that glucocorticoids, a class of steroid hormones that are commonly prescribed as drugs, enhance muscle endurance and alleviate muscular dystrophy through activation of the gene KLF15.

October 20, 2015

SAN FRANCISCO, CA—Nobel Prize winner Shinya Yamanaka, MD, PhD, a Senior Investigator at the Gladstone Institutes in San Francisco, has been elected to the National Academy of Medicine.

October 14, 2015

SAN FRANCISCO, CA—Scientists from the Gladstone Institutes have discovered that blood-derived T cells are resistant to the chief cause of cell death in HIV infection.

October 9, 2015

SAN FRANCISCO, CA—A new study from the Gladstone Institutes shows that a single drop of blood in the brain is sufficient to activate an autoimmune response akin to multiple sclerosis (MS).

September 24, 2015

SAN FRANCISCO, CA—Scientists from the Gladstone Institutes have provided a detailed map of how basic research translates into new treatments for deadly diseases.

September 21, 2015

SAN FRANCISCO, CA—Scientists from the Gladstone Institutes have discovered that salsalate, a drug used to treat rheumatoid arthritis, effectively reversed tau-related dysfunction in an animal model of frontotemporal dementia (FTD).

September 14, 2015

SAN FRANCISCO, CA—A new study from the Gladstone Institutes shows for the first time that impairments in mitochondria—the brain’s cellular power plants—can deplete cellular energy levels and cause neuronal dysfunction in a model of neurodegenerative disease.

Pages